Positive expressions of Pan-Cytokeratin and CK20 are commonly used to differentiate between MCC from other tumor origins, including melanoma and other metastatic neuroendocrine tumors (Fig. 2a,b, iii and iv)19. The gene discussed is KRT20; the disease is Merkel cell skin cancer.